Project Grant HT94252510255

Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $1.4M
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Westlake, MD 20817, USA
Similar Awards
The Defense Health Agency awarded a $478,061 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). This grant, with a performance period from September 1, 2024 to August 31, 2026, supports the development of an organoid model for ovarian cancer research and precision medicine. The Henry M. Jackson Foundation, a global non-profit organization, will use this funding to advance...
The Department of Defense's Defense Health Agency awarded a $783,023 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant supports a 3-year research project titled "A Precision-Medicine Approach to Targeting Acquired Therapeutic Resistance in RTK-Mutated NSCLC". This research aims to transform healthcare for military service members, veterans, and the broader...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,460,695.00 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to support the "Development and Validation of an Epigenomic Landscape and Novel Immunotherapy in Prostate Cancer Disparities" research project. The award period runs from September 1, 2025 to August 31, 2028. The funded research aims to...
The Department of Defense's Defense Health Agency awarded a $1,297,813 Cooperative Agreement to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). This award, with a performance period from September 1, 2023 to August 31, 2027, aims to enhance functional restoration and accelerate return to duty following lower extremity autologous free-flap harvest procedures. As a global non-profit...
The Defense Health Agency awarded a $856,523 project grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on the neurovascular and cognitive recovery from the spectrum of traumatic brain injuries through high-low...
The Defense Health Agency awarded a $488,086 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the grant will fund research on "BIOMARKER SIGNATURES OF POST-TRAUMATIC EPILEPTOGENESIS (PTEGENESIS) AND ITS...
This $749,822 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to develop transformative multistaged treatment approaches for composite tissue injuries. The research aims to transform healthcare for military service members, veterans, and the broader public. The award has a performance period from...
This $4,626,921 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The grant was awarded on August 1, 2025 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit organization in Bethesda, Maryland. The research aims to elucidate the role of the...
The Department of Defense's Defense Health Agency awarded a $752,148 Cooperative Agreement on September 15, 2023 to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year research project investigating the maternal, fetal, and infant outcomes associated with malaria prophylactic medication exposure. The work will be performed in Westlake, MD. The Henry M. Jackson...
The Department of the Army Medical Command awarded a $1,898,000 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports the development of a rapid, field-deployable nanopore sequencing-based assay to improve clinical decision-making and patient management for military personnel and the general public. The 3-year project aims to advance diagnostic and...

The Department of Defense's Defense Health Agency has awarded a $1,390,847 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant, with a performance period from September 1, 2025 to August 31, 2028, will support research to investigate the mechanistic role and therapeutic targeting of the cohesin RAD21 protein in metastatic prostate cancer. As a non-profit organization dedicated to supporting military medical research, the foundation will conduct this advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public.

Generated 8/5/25, 3:26 AM